Genetic deletion of COX or PGE2 inhibits cancer in subcutaneous tumor models, and pharmacological inhibition using celecoxib was found to be a potent cancer-preventative measure in a mouse intestinal tumor model driven by mutant APC (57, 58). Here, APC is linked to cancer.